Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,384 | -4,242 | -2,504 | -16,022 | -15,365 |
| Depreciation Amortization | 206 | 121 | 83 | 38 | 17 |
| Accounts receivable | 318 | -423 | -7 | 399 | -786 |
| Accounts payable and accrued liabilities | 114 | 145 | -5 | -583 | 234 |
| Other Working Capital | 1,040 | 83 | -23 | -241 | -506 |
| Other Operating Activity | 665 | 1,155 | 152 | 923 | 3,157 |
| Operating Cash Flow | $-7,041 | $-3,161 | $-2,304 | $-15,486 | $-13,249 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,714 | -40 | N/A | 9,000 | 10,000 |
| PPE Investments | -189 | -461 | -130 | -18 | -48 |
| Other Investing Activity | 1,544 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-6,359 | $-501 | $-130 | $8,982 | $9,952 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,306 | 5,194 | N/A | 6,089 | N/A |
| Other Financing Activity | 0 | 0 | 8,055 | 0 | 0 |
| Financing Cash Flow | $8,306 | $5,194 | $8,055 | $6,089 | $N/A |
| Exchange Rate Effect | 826 | -772 | 364 | N/A | N/A |
| Beginning Cash Position | 9,792 | 9,032 | 3,020 | 7,286 | 10,583 |
| End Cash Position | 5,524 | 9,792 | 9,005 | 6,871 | 7,286 |
| Net Cash Flow | $-4,268 | $760 | $5,985 | $-415 | $-3,297 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,041 | -3,161 | -2,304 | -15,486 | -13,249 |
| Capital Expenditure | -193 | -461 | -130 | -18 | -48 |
| Free Cash Flow | -7,234 | -3,622 | -2,434 | -15,504 | -13,297 |